发明名称 BICYCLIC PYRIMIDINE MATRIX METALLOPROTEINASE INHIBITORS
摘要 Selective MMP-13 inhibitors are bicyclic pyrimidines of the Formula I or a pharmaceutically acceptable salt thereof, wherein R<SUP>1 </SUP>is hydrogen or alkyl; R<SUP>2</SUP>, R<SUP>3</SUP>, and R<SUP>4 </SUP>include hydrogen, halo, alkyl, C≡C(CH<SUB>2</SUB>)<SUB>m </SUB>aryl, CO<SUB>2 </SUB>alkyl, CO<SUB>2</SUB>(CH<SUB>2</SUB>)<SUB>m </SUB>aryl, COHN alkyl, and CONH(CH<SUB>2</SUB>)<SUB>m </SUB>aryl; and X is O, S, SO, SO<SUB>2</SUB>, CH<SUB>2</SUB>, C-O, CHOH, NH, or NR<SUP>5</SUP>. A compound of Formula I, or a pharmaceutically acceptable salt thereof, is useful for treating cancer or arthritis.
申请公布号 US2006040957(A1) 申请公布日期 2006.02.23
申请号 US20020071032 申请日期 2002.02.08
申请人 DYER RICHARD D;HARTER WILLIAM G;HICKS JAMES L;JOHNSON ADAM R;LI JIE J;ROARK WILLIAM H;SHULER KEVON R 发明人 DYER RICHARD D.;HARTER WILLIAM G.;HICKS JAMES L.;JOHNSON ADAM R.;LI JIE J.;ROARK WILLIAM H.;SHULER KEVON R.
分类号 A61K31/519;A61K31/5377;A61P1/02;A61P1/04;A61P9/04;A61P9/10;A61P19/02;A61P19/10;A61P25/00;A61P27/02;A61P29/00;A61P35/00;A61P43/00;C07D487/04;C07D498/04;C07D513/04;C07D519/00 主分类号 A61K31/519
代理机构 代理人
主权项
地址